Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barriers to Effective Communication II01:21

Barriers to Effective Communication II

3.7K
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
3.7K
Vaccinations01:51

Vaccinations

44.5K
Overview
44.5K
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

207
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
207
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.3K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.3K
Development of Immunocompetence01:22

Development of Immunocompetence

309
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
309
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

941
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
941

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How Can We Prevent a Resurgence of Vaccine Nationalism?

International journal of health policy and management·2025
Same author

Hoarding Vaccines or Hedging Vaccine R&D Risks? - Motivation for Overbooking COVID-19 Vaccines in High-Income Countries.

International journal of health policy and management·2024
See all related articles

Related Experiment Video

Updated: Jul 5, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

Why does the COVAX facility fail to bridge the 'immunization gap'?

Qi Shao1,2

  • 1Nanjing University of Aeronautics and Astronautics, Nanjing, China. 598152706@qq.com.

Journal of Public Health Policy
|January 19, 2024
PubMed
Summary
This summary is machine-generated.

The COVID-19 Vaccines Global Access (COVAX) Facility aimed for equitable vaccine distribution but fell short due to incentive, allocation, and enforcement issues. Transforming COVAX into an information hub could improve global immunization progress.

Keywords:
COVAX facilityCOVID-19 vaccineEquitable accessImmunization gap

More Related Videos

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.2K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.0K

Related Experiment Videos

Last Updated: Jul 5, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K
Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.2K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.0K

Area of Science:

  • Global Health Policy
  • Vaccinology
  • International Relations

Background:

  • The World Health Organization initiated the COVID-19 Vaccines Global Access (COVAX) Facility in April 2020.
  • COVAX was designed to ensure equitable global access to COVID-19 vaccines.
  • Despite its innovative approach, COVAX has struggled to bridge the immunization gap between high-income and low-income nations.

Purpose of the Study:

  • To analyze the shortcomings of the COVAX Facility in achieving equitable global vaccine distribution.
  • To identify key constraints limiting COVAX's effectiveness.
  • To propose a transformation of COVAX to enhance its impact on global immunization.

Main Methods:

  • Policy analysis of the COVAX Facility's structure and implementation.
  • Examination of incentive mechanisms for participating self-financing countries.
  • Assessment of vaccine allocation strategies considering political and ethical factors.
  • Evaluation of financing and enforcement capabilities.

Main Results:

  • COVAX faced challenges due to inadequate incentives for self-financing countries.
  • The vaccine allocation mechanism did not sufficiently incorporate national political considerations or medical ethics.
  • Lack of independent financing and global enforcement power constrained COVAX's effectiveness.
  • The 'immunization gap' between high-income and low-income countries persists.

Conclusions:

  • COVAX's current structure limits its ability to ensure equitable vaccine access.
  • Reforming COVAX into an information center for vaccine supply, demand, knowledge dissemination, and aid requests could accelerate progress.
  • Strengthening financing and enforcement mechanisms is crucial for future global health initiatives.